Member Info for ajithoth

info on celgene\bms psoriasis monopoly here:
https://www.fiercepharma.com/pharma/ftc-zeroes-potential-bristol-myers-celgene-s-psoriasis-overlap

what makes you say that Ahfam?

well I didn't dodge the bullet with either VAL or PYC.
I'm at about my average price in here after buying on a spoke at 3.2p many years ago.
Averaged down at ~0.25P a few years back.
But well under water with VAL and PYC.

ahem. he was 100% correct though Marineville.
He also put me off getting invested there.
So I owe him one for that.

https://community.prostatecanceruk.org/posts/t16349-Clinical-Trials--My-New-Journey#

https://www.nytimes.com/2019/02/28/business/dealbook/pharmaceutical-biotech-acquisitions.html

It's 15% up. Reckon it'll be a good day for us.

Hi Aberystwyth - on a reread its nothing new. I think its the latter, stopped development and up for sale.
update dated yesterday which is why I noticed it.
It's actually dated from the 2016 so please accept my apologies....

Drug Summary

Global Status
Discontinued

Development Status
Ceased

Latest Change
Discontinuation of development reported

Latest Change Date
2019/01/10

Summary
Sareum has discontinued the development of small molecule inhibitors of aurora A and B and FLT3 using its SKIL platform, for the treatment of acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL), due to the discontinuation of further investment and seeking licence partner (Company presentation, Sareum, 19 May 2016, Slide 8,

thats incorrect - they hit 32p last december. I sold at 28p which was more luck that skill. Pity I'd only bought £500 worth at 10p.

News alert - SAR - Preclinical Data for SRA737 in Ovarian Cancer

A cure for cancer: how to kill a killer

https://www.theguardian.com/science/2018/nov/04/a-cure-for-cancer-how-to-kill-a-killer-revolutionary-immune-system-immunotherapy?CMP=Share_AndroidApp_Copy_to_clipboard

I don't get this, its almost as if the placing has had a positive effect on the sp which is contrary to normal.
We just need that near 10% spread to start closing now.

http://www.pharmatimes.com/magazine/2018/october_2018/ai_has_arrived

Notice of Final Results for the Year Ended 30 June 2018

Sareum Holdings plc (AIM: SAR), the specialist in small molecule drug development, announces that it will release its results for the full year ended 30 June 2018 on or around Monday, 1 October 2018.

It's probably nowhere near as selective as Sars https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421857
Do we own the patent on Tyk2 inhibitor or just the chemical process that creates the drug?

Hi Searle, no the pension pot is completely separate with work....

I'm 48 too Potnak - mortgaged until 65. >90% of my pot is in SAR.
I'm not nervous.

BYOT looks interesting. Never heard of them to be honest.
Rather than use a new AB to fight MRSA, kill the bugs in the first place, might chuck a bag of sand at it next week.
Potnak, I'm not selling either, its boom or bust for me. I'd never forgive myself if I welched out now and it went to 3,5, 10 or 30p.

Good to see you have got some VAL and PYC Thoth2 - I hold them too but I'm about 30% down atm.
Hoping to cash them in with a decent profit soon.
The vast majority of my holdings are in SAR though.
I really hope for everyone that it all becomes more than worth it for waiting so long.

Aver - I was replying to JonBell.